𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B

✍ Scribed by Nikolaos Nikolaidis; Themistoklis Vassiliadis; Olga Giouleme; Konstantinos Tziomalos; Nikolaos Grammatikos; Kalliopi Patsiaoura; Eleni Orfanou-Koumerkeridou; Aikaterini Balaska; Nikolaos Eugenidis


Book ID
110889524
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
94 KB
Volume
19
Category
Article
ISSN
0902-0063

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Comparison of interferon and lamivudine
✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Masahiro Kobayashi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

## Abstract The aim of this study was to elucidate the long‐term outcome after interferon (IFN) or lamivudine (LMV) treatment in Japanese patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis B. Inclusion criteria were biopsy proven chronic hepatitis or liver cirrhosis, no history

Analysis of the complete hepatitis B vir
✍ KaiYu Zhang; Fumio Imazeki; Kenichi Fukai; Makoto Arai; Tatsuo Kanda; Rintaro Mi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 2 views

## Abstract To investigate the relationship between viral factors and the development of chronic hepatitis B, the entire hepatitis B virus (HBV) genome of chronic carriers at different disease stages were analyzed. Eighty genotype C HBV carriers including 12 hepatitis B e antigen (HBeAg) positive a